Study guide
9.4 Managing Co-Occurring Symptoms in Counseling
NAADAC Master Addiction Counselor MAC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & MAC Exam Overview
1.1 About the MAC Exam, Eligibility & Kryterion Format 1.2 Content Blueprint, Scoring Standards & Study Strategy
2 Chapter 2: Orientation to the Treatment Process & Continuum of Care
2.1 Patient Intake, Engagement & Screening Workflows 2.2 ASAM Criteria & Levels of Care Continuum 2.3 Referral Systems, Service Coordination & Patient Advocacy 2.4 Client Rights, Program Orientation & Informed Consent
3 Chapter 3: Biopsychosocial Assessment & Diagnostic Evaluation
3.1 Comprehensive Biopsychosocial Assessment Architecture 3.2 DSM-5-TR Diagnostic Criteria for Substance Use Disorders 3.3 Standardized Screening & Assessment Tools (AUDIT, CAGE, DAST, GAIN) 3.4 The Six ASAM Assessment Dimensions & Risk Rating
4 Chapter 4: Co-Occurring Disorders & Differential Diagnosis
4.1 Co-Occurring Psychiatric Disorders & Integrated Screening 4.2 Trauma-Informed Assessment & PTSD Screening 4.3 Suicide Risk Assessment & Immediate Safety Planning 4.4 Cultural Competence & Diversity in Clinical Assessment
5 Chapter 5: Individualized Treatment Planning & Goal Setting
5.1 Individualized Treatment Plan Development & Problem Identification 5.2 Formulating SMART Goals & Measurable Objectives 5.3 Matching ASAM Dimensions to Levels of Care & Interventions 5.4 Patient-Centered Planning, Readiness to Change & Client Autonomy
6 Chapter 6: Treatment Implementation, Care Coordination & Review
6.1 Continuous Treatment Plan Review & Progress Evaluation 6.2 Interprofessional Collaboration & Multidisciplinary Care 6.3 Case Management & Social Determinants of Recovery 6.4 Discharge Planning, Continuing Care & Transition Management
7 Chapter 7: Individual & Group Addiction Counseling Practices
7.1 Core Individual Counseling Micro-Skills & Therapeutic Alliance 7.2 Group Counseling Dynamics, Process & Facilitation 7.3 Family Systems, Codependency & Enabling Dynamics 7.4 Client & Family Psychoeducation on Addiction Science
8 Chapter 8: Evidence-Based Modalities & Therapeutic Interventions
8.1 Motivational Interviewing (MI) Principles, OARS & Change Talk 8.2 Transtheoretical Model (Stages of Change) & Matching Interventions 8.3 Cognitive-Behavioral Therapy (CBT) & Cognitive Restructuring 8.4 Trauma-Informed Care & Crisis Intervention Strategies
9 Chapter 9: Pharmacotherapy & Relapse Prevention Strategies
9.1 Addiction Pharmacotherapy (MAT/MAR: Methadone, Buprenorphine, Naltrexone, Acamprosate) 9.2 Relapse Prevention Models (Marlatt), Triggers & High-Risk Situations 9.3 Harm Reduction Principles & Overdose Prevention 9.4 Managing Co-Occurring Symptoms in Counseling
10 Chapter 10: Legal & Confidentiality Regulations
10.1 42 CFR Part 2 Federal Confidentiality Regulations & Consent Requirements 10.2 HIPAA Privacy/Security Rules vs. 42 CFR Part 2 Differences & Interplay 10.3 Medical Emergencies, Crime on Premises & Court Order Exceptions 10.4 Mandatory Child/Elder Abuse Reporting & Duty to Warn (Tarasoff)
11 Chapter 11: Professional Ethics, Boundaries & Supervision
11.1 NAADAC Code of Ethics Principles & Ethical Decision-Making Models 11.2 Professional Boundaries, Dual Relationships & Scope of Practice 11.3 Clinical Documentation Standards (SOAP, BIRP, DAP) & Record Integrity 11.4 Clinical Supervision, Counselor Burnout & Professional Wellness
9.4 Managing Co-Occurring Symptoms in Counseling
Key Takeaways Explain This Topic AI
Co-occurring psychiatric symptoms (anxiety, depression, insomnia) frequently surge during early recovery due to neurobiological recalibration and Post-Acute Withdrawal Syndrome (PAWS).
Non-pharmacological counseling interventions—including CBT, dialectical behavior skills, somatic grounding, and behavioral activation—provide effective first-line management for psychiatric distress in early SUD recovery.
Structured sleep hygiene protocols address PAWS-related sleep disturbances, mitigating insomnia as a major precipitant of substance relapse without relying on addictive sedative-hypnotics.
Clients with chronic pain and SUD history require non-opioid, multidisciplinary pain management strategies involving CBT for chronic pain, physical therapy, and non-opioid analgesics.
Master-level counselors must actively collaborate with prescribing medical providers to ensure safe psychiatric pharmacotherapy, avoiding high-abuse-potential agents (e.g. benzodiazepines, stimulants) while supporting non-addictive psychiatric medications.
Last updated: August 2026
9.4 Managing Co-Occurring Symptoms in Counseling
Quick Summary: In early addiction recovery, clients frequently experience acute flare-ups of co-occurring psychiatric symptoms—including severe anxiety, depressive mood, anhedonia, emotional dysregulation, insomnia, and chronic pain. These symptom surges are driven by a combination of pre-existing psychiatric conditions and neurobiological recalibration associated with Post-Acute Withdrawal Syndrome (PAWS). Master addiction counselors must deploy non-pharmacological coping interventions, structured sleep hygiene protocols, evidence-based pain management strategies, and collaborative interprofessional communication with prescribers to maintain safety and recovery stability.
Co-Occurring Symptom Dynamics in Early Recovery
During the early weeks and months of abstinence, the central nervous system undergoes gradual neuroadaptation. Chronic substance exposure suppresses endogenous neurotransmitter production (dopamine, serotonin, GABA, endorphins) and alters receptor sensitivity. When substances are discontinued, clients enter a prolonged phase of neurobiological vulnerability known as Post-Acute Withdrawal Syndrome (PAWS) .
Clinical Manifestations of PAWS & Co-Occurring Distress
Emotional Volatility & Anxiety: Hyper-reactivity of the amygdala and extended amygdala stress systems (corticotropin-releasing factor [CRF], noradrenaline) produces intense rebound anxiety, panic attacks, and agitation.
Depressive Mood & Anhedonia: Down-regulated dopamine (D2) receptors in the nucleus accumbens lead to severe anhedonia—the inability to experience pleasure from natural rewards—and profound depressive apathy.
Cognitive Impairment: Prefrontal cortex dysfunction causes memory deficits, executive dysfunction, poor concentration, and rigid thinking.
Sleep Disturbances: Disrupted circadian rhythms, loss of slow-wave sleep, and REM rebound induce persistent insomnia and distressing dreams.
Clinical Challenge
If these co-occurring symptoms are left unaddressed, clients frequently experience unbearable distress, leading them to self-medicate with alcohol, illicit drugs, or unprescribed medications. Counselors must intervene early with structured non-pharmacological and collaborative strategies.
Non-Pharmacological Management of Early Recovery Anxiety
When clients experience co-occurring anxiety flare-ups, counselors must provide immediate, non-pharmacological somatic and cognitive tools to restore physiological regulation.
Somatic & Grounding Interventions
The 5-4-3-2-1 Sensory Grounding Technique: Directs client attention away from internal panic loops onto external sensory stimuli:
Name 5 things you can see around you.
Name 4 things you can physically feel (e.g., feet on the floor, chair back).
Name 3 distinct sounds you can hear.
Name 2 scents you can smell.
Name 1 taste in your mouth.
Diaphragmatic & Box Breathing: Paced respiration (inhale for 4 seconds, hold for 4 seconds, exhale for 4 seconds, hold for 4 seconds) stimulates the vagus nerve, increasing parasympathetic tone and lowering heart rate.
DBT TIPP Skills (Distress Tolerance):
T — Temperature: Splashing cold water on the face or holding an ice pack triggers the mammalian dive reflex, rapidly slowing heart rate.
I — Intense Exercise: Short bursts of exercise (jumping jacks, fast walking) burn off excess adrenaline.
P — Paced Respiration: Slow, deep exhalations longer than inhalations.
P — Paired Muscle Relaxation: Tensing and releasing muscle groups sequentially.
Cognitive Restructuring for Anxiety
Counselors guide clients to identify automatic thoughts (e.g., "This anxiety will kill me," "I can't survive without using" ), examine empirical evidence, evaluate worst-case vs. realistic probabilities, and construct balanced coping statements ( "Anxiety is uncomfortable, but it is a temporary physiological wave that will pass within 20 minutes" ).
Addressing Depressive Symptoms & Anhedonia
Anhedonia and depressive mood during early abstinence are major drivers of treatment drop-out. Counselors utilize Behavioral Activation (BA) —an core CBT intervention—to break the cycle of withdrawal, lethargy, and isolation.
Behavioral Activation Protocol
Activity Monitoring: The client logs hourly activities, rating each on a 0–10 scale for Mastery (sense of accomplishment) and Pleasure (enjoyment).
Targeted Activity Scheduling: Counselors work with the client to schedule small, manageable daily activities focused on:
Mastery: Completing basic tasks (making the bed, paying a bill, preparing a healthy meal).
Pleasure: Re-engaging in low-stress recreational hobbies, listening to music, walking outdoors.
Graded Task Assignments: Complex tasks are broken down into micro-steps to prevent overwhelm.
By engaging in scheduled behaviors regardless of internal mood state, behavioral activation stimulates natural dopamine pathways, gradually reversing recovery-induced anhedonia.
Sleep Hygiene Protocols & Insomnia Management
Insomnia is one of the most common PAWS symptoms and a primary predictor of substance relapse. Counselors adapt Cognitive Behavioral Therapy for Insomnia (CBT-I) principles to establish non-pharmacological sleep hygiene:
Core Sleep Hygiene Rules for Recovery
Domain Intervention Protocol
Fixed Wake Time Maintain a strict, non-negotiable wake-up time 7 days a week, regardless of total sleep hours.
Stimulus Control The bed is used strictly for sleep and intimacy. If awake after 20 minutes, get out of bed, go to a dimly lit room, read non-stimulating material, and return only when sleepy.
Screen & Light Hygiene Eliminate blue-light screens (phones, TVs, computers) at least 60 minutes before bedtime to allow natural melatonin secretion.
Substance & Caffeine Control Stop caffeine consumption after 12:00 PM. Avoid nicotine within 2 hours of bedtime. Avoid OTC sedative sleep aids (diphenhydramine) due to anticholinergic side effects and misuse potential.
Daytime Napping Strictly eliminate daytime naps to build homeostatic sleep pressure for nighttime sleep.
Non-Opioid Pain Management in SUD Recovery
A significant proportion of individuals entering addiction treatment present with co-occurring chronic non-cancer pain. Counselors must employ a Biopsychosocial Pain Model and advocate for non-opioid interventions:
Cognitive Behavioral Therapy for Chronic Pain (CBT-CP)
Pain Re-Education: Teaching clients that pain signals are interpreted by central nervous system networks influenced by stress, attention, and mood. Pain intensity does not equal ongoing tissue damage.
Activity Pacing: Teaching clients to pace daily physical activities, avoiding the "overactivity-crash" cycle where clients overexert on good days and become bedridden on bad days.
Uncoupling Pain from Suffering: Helping clients separate the physical nociceptive sensation from catastrophic cognitive interpretations ( "My life is ruined by this pain" ).
Multidisciplinary Non-Opioid Modalities
Physical & Somatic Interventions: Physical therapy, aquatic therapy, acupuncture, massage, and Transcutaneous Electrical Nerve Stimulation (TENS).
Non-Opioid Medical Options: Nonsteroidal anti-inflammatory drugs (NSAIDs like ibuprofen, naproxen), acetaminophen, topical lidocaine patches, capsaicin cream, and non-addictive adjuvant medications.
Interprofessional Collaboration & Safe Psychiatric Prescribing
Master addiction counselors work closely with prescribing physicians, psychiatrists, and nurse practitioners to coordinate safe psychiatric care.
High-Risk vs. Preferred Psychiatric Medications in SUD
High-Risk Medications to Avoid or Avoid/Exercise Extreme Caution:
Benzodiazepines (Alprazolam, Diazepam, Clonazepam, Lorazepam): High abuse potential, rapid physical dependence, severe withdrawal seizures, and fatal respiratory depression when combined with opioids or alcohol.
Schedule II CNS Stimulants (Methylphenidate, Amphetamine Salts): High misuse potential in individuals with stimulant or polysubstance histories.
Sedative-Hypnotics (Z-drugs: Zolpidem, Eszopiclone): Possess GABA-A receptor misuse potential similar to benzodiazepines.
Preferred Non-Addictive Psychiatric Medications:
Anxiety & Depression: Selective Serotonin Reuptake Inhibitors (SSRIs: Sertraline, Escitalopram, Fluoxetine) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs: Duloxetine, Venlafaxine).
Generalized Anxiety: Buspirone (non-addictive 5-HT1A partial agonist; no abuse potential or dependence).
Acute Anxiety / Agitation: Hydroxyzine (an H1 antihistamine providing non-addictive sedation and anxiety relief).
Insomnia: Low-dose Trazodone, Mirtazapine, or Doxepin.
Gabapentinoids Caution: Gabapentin and Pregabalin are useful for neuropathic pain and anxiety, but require close monitoring due to emerging misuse potential, particularly among individuals with opioid use disorder.
Counselor Communication Protocols
Counselors must secure valid Release of Information (ROI) forms, transmit clear diagnostic summaries to prescribers, communicate the client's addiction history, monitor medication compliance, and report emerging side effects or misuse behaviors promptly.